January 13, 2017
Takeda Pharmaceutical will invest US$125 million in Maverick to get its hands on the US biotech’s T-cell engagement platform for cancer treatments, eyeing its possible acquisition - the latest in the Japanese drug giant’s collaboration spree aimed at boosting its...read more